Note: Descriptions are shown in the official language in which they were submitted.
CA 02340119 2001-02-19
WO 00/10889 PCT/US99/16948
ACTUATOR SYSTEM FOR SPRAYING A FORMULATION
ONTO A HOST
FIELD OF THE INVENTION
This invention is in the field of devices that deliver therapeutically
effective
liquids onto a host, such as a human. More specifically, this invention
relates to an
actuator system for spraying therapeutically effective liquids from a vial
onto a host with
great precision, accuracy and control.
BACKGROUND OF THE INVENTION
Transtissue drug delivery is a non-invasive therapeutic method in which a
drug is first placed onto a tissue of a host animal and then caused to
penetrate into the
tissue in furtherance of the desired therapeutic treatment. Transtissue drug
delivery can be
used to treat topical, local, or systemic medical conditions. Delivery can
occur across a
number of different tissues including the skin, mucosal membranes, or the
like. Delivery
through the skin is generally referred to as "transdermal" drug delivery.
Transdermal drug delivery is typically accomplished by using a covering
element in the form of a transdermal patch device that is attached to the host
at the desired
drug delivery site. A conventional "peel and place" transdermal patch device
generally
includes a drug-in-adhesive layer sandwiched between an impermeable backing
and a
release liner. At the time of use, the release liner is easily removed so that
the patch can be
attached to the host, adhesive side down. The impermeable backing thus traps
the drug
between the backing and the attachment site of the host. Over time, the drug
penetrates
into the host, or is topically active, in furtherance of the desired
therapeutic treatment.
Optionally, the drug-in-adhesive formulation may include one or more compounds
known
as penetration enhancers that increase the permeability of the tissue to the
drug.
Although the peel and place type of transtissue drug delivery device has
been an extremely effective means to accomplish drug delivery for a wide
variety of
1
CA 02340119 2001-02-19
WO 00/10889 PCT/US99/16948
medical conditions, there are still a number of ways in which transtissue drug
delivery
could be improved. For instance, the structure of the conventional peel and
place patch
currently involves a manufacturing operation requiring the drug-in-adhesive to
be coated
onto a substrate, such as the release liner or the impermeable backing as the
case may be.
This kind of coating step involves substantial expense in terms of capital
equipment,
utilities, manufacturing space, and human resources needed to carry out the
coating
operation. To avoid such expense, it would be desirable if a way could be
found to
eliminate the need for such a coating step.
As another example, the use of a release liner is less than environmentally
friendly in the sense that the release liner becomes an item of waste that
must be discarded
in some fashion after being removed from its patch. It would be desirable if a
way could
be found to avoid this kind of waste.
Another area of improvement concerns the ability to more effectively
control the rate of drug delivery. For current patches, the rate of drug
delivery is initially
relatively high when the concentration of the drug in the patch is still
relatively high.
However, as the drug is depleted, the rate of drug delivery slows down. It
would be
desirable to provide a patch that is characterized by a steady, consistent
rate of drug
delivery over a longer period of time.
Assignee's co-pending U.S. Patent Application entitled SPRAY ON
BANDAGE AND DRUG DELIVERY SYSTEM having docket number 53867USASA
and filed August 20, 1998 (incorporated herein by reference in its entirety),
describes a
novel "patch in a bottle" technology in which a fluid composition, e.g. an
aerosol
spray, is applied onto a substrate as a fluid, but then dries to form a
composite covering
element, such as a patch, having a tack free outer surface covering an
underlying
adhesive that helps adhere the patch to the substrate. The fluid compositions
have a
unique chemical formulation that allows such composite patches to form in
situ.
Specifically, the fluid compositions include a tacky component, such as an
adhesive,
and a film forming, non-tacky component. The non-tacky and tacky components
are
selected to be immiscible with each other so that the components undergo phase
separation as the fluid composition dries. The non-tacky component has
characteristics
that cause it to seek the surface of a coating, where it dries to form a non-
tacky
2
CA 02340119 2001-02-19
WO 00/10889 PCT/US99/16948
protective film. The tacky component dries below this film, providing the
bottom
surface of the patch with a sufficient tack to adhere to the substrate. One or
more
pharmacologically active agents are easily incorporated into the fluid
compositions so
that the fluid compositions and corresponding patches can be used for
transtissue drug
delivery, e.g. transdermal drug delivery, delivery through a mucosal membrane,
or the
like.
When applying the patch in bottle formulations to a host in which such
formulations include a pharmacologically active agent, it is important that
the
application of the formulations be accurately controlled so that the patient
receives a
proper dosage. What is needed is a way to administer these formulations in a
manner
that allows such control.
SUMMARY OF THE INVENTION
The present invention provides a method and system that accurately and
precisely administers formulations from a vial onto any desired surface. The
invention
is particularly suitable for controllably and consistently dispensing uniform
dosages of
therapeutically effective compositions, such as the "patch in a bottle"
formulations of
Assignee's co-pending application, onto a host animal, such as a human or
other
mammal.
As an overview, the system preferably is used to dispense a defined
volume of a formulation from a pressurized vial. The system houses the vial in
a
receptacle of a base section that also includes a dispensing section (e.g., a
funnel)
through which the formulation is sprayed. Advantageously, when used with
therapeutically active, sprayable compositions, such as the patch in a bottle
formulations of Assignee's copending application, the dispensing section can
be sized
and shaped so that a precisely sized patch formed from a precise volume of a
precise
composition is formed on the host. This helps to ensure that the resultant
patch very
accurately delivers the desired dosage of a pharmacologically active agent to
the host.
3
CA 02340119 2001-02-19
WO 00/10889 PCT/US99/16948
The system preferably includes a sleeve that fits over at least the vial and
that can be pumped by the user to controllably spray the formulation from the
vial onto
the host animal. For instance, in a preferred mode of operation, the user
places the
system onto the host at the desired treatment site and then pushes or pulls
down on the
sleeve. This actuates a valve mechanism on the vial to spray an amount of the
formulation through the dispensing section onto the host. The spray travels
through the
dispensing section along a pathway having a substantially linear longitudinal
axis so
that as much of the spray as possible reaches the host. Preferably, the
formulation can
travel from the vial to the host over a relatively short distance. This also
minimizes
the amount of formulation that would be lost during spraying.
As another advantage, the use of such a linear dispensing section allows
a precise amount of uniformly sized droplets of the formulation to be sprayed
from a
uniform height (determined by the height of the dispensing section) over a
uniform
area (determined by the outlet of the dispensing section). As a consequence, a
uniform
dosage of the formulation is applied to the host each time that the system is
actuated,
because, with each actuation, the dosage will cover substantially the same
surface area
at substantially the same thickness.
The sleeve itself also offers many performance advantages. First, the
sleeve helps to maintain proper alignment between the vial and the base
section.
Second, the sleeve forms a protective envelope around the vial. The sleeve
keeps the
vial from falling out of the base section and protects the vial during
storage, shipping,
or use. Third, the sleeve makes it easier for the user to dispense an amount
of
formulation from the vial, especially for the elderly.
In one aspect, the present invention provides an actuator system for
applying a sprayable formulation from a vial onto a limited surface area of a
host. The
system includes a base section comprising a dispensing section having an
interior
through which an amount of the formulation can be sprayed onto the surface
area. The
dispensing section comprises a throat at which the amount of the formulation
enters the
dispensing section and a mouth at which the amount of the formulation exits
the
dispensing section. The base section also includes a receptacle comprising a
structure
4
CA 02340119 2001-02-19
WO 00/10889 PCT/US99/16948
that operationally couples the vial to the dispensing section so that the
formulation can
be dispensed from the vial into the throat of the dispensing section. A sleeve
is adapted
to fit over at least a portion of the vial when the vial is positioned in the
receptacle.
The sleeve has a range of motion extending from a first position to a second
position,
wherein movement of the sleeve from the first position to the second position
causes
said amount of formulation to be dispensed into the dispensing section. The
vial is
closed when the sleeve is in the first position, and the sleeve is biased
toward the first
position.
In another aspect, the present invention relates to an actuator system for
applying a sprayable formulation from a vial onto a limited surface area of a
host. The
system includes a base section that includes a dispensing section through
which an
amount of the formulation can be sprayed onto said surface area. The
dispensing
section comprises a throat at which the amount of the formulation enters the
dispensing
section and a mouth at which the amount of the formulation exits the
dispensing
section. The dispensing section comprises at least one vent in open
communication
with the ambient. The base section also includes a receptacle comprising a
structure
that operationally couples the vial to the dispensing section so that the
formulation can
be dispensed from the vial into the throat of the dispensing section.
In another aspect, the present invention relates to an actuator system for
applying a sprayable formulation from a vial onto a defined surface area of a
host. The
actuator system comprises a base section comprising a dispensing section. The
dispensing section includes a pathway through which an amount of the
formulation
may be sprayed from a uniform height over said surface area. The dispensing
section
comprises a substantially linear longitudinal axis extending from a throat at
which the
amount of formulation enters the dispensing section to a mouth at which the
formulations exits from the dispensing section. A receptacle comprises a
structure that
operationally couples the vial to the dispensing section so that the amount of
the
formulation can be dispensed from the vial through the dispensing section. The
receptacle comprises a cup for housing at least a portion of the vial. The cup
comprises
one or more vents providing open communication between the cup and the
ambient.
5
CA 02340119 2001-02-19
WO 00/10889 PCTNS99/16948
BRIEF DESCRIPTION OF THE DRAWINGS
The above mentioned and other advantages of the present invention, and
the manner of attaining them, will become more apparent and the invention
itself will
be better understood by reference to the following description of the
embodiments of
the invention taken in conjunction with the accompanying drawings, wherein:
Figure 1 is an exploded perspective view of an actuator system of the
present invention.
Figure 2 shows the actuator system of Figure I being used on a host.
Figure 3a is a top view of the base section used in the actuator system of
Figure 1, showing the centrally located orifice and vent holes located around
that
orifice in the bottom of the receptacle portion of the base section.
Figure 3b is an end view of the sleeve from the actuator system of Fig. l,
when the inside of the sleeve is shown.
Figure 4a is a cross-sectional side view of the base section used in the
actuator system of Figure 1.
Figure 4b is an alternative embodiment of a base section such as that
shown in Figure 4a except in Figure 4b the ribs on the base section include
cut-out
portions proximal to the fingers to make it easier to resiliently depress the
fingers when
removing or placing a sleeve onto the base section.
Figure Sa is a cross-sectional side view of a preferred metered dose,
valued dispensing element suitable for use in the acuator system of Figure 1,
wherein
the valued dispensing element is shown in a closed position with the stem
extended.
Figure Sb is a cross-sectional side view of the valued dispensing element
of Figure Sa, wherein the valued dispensing element is in an open position
with the
stem being depressed.
Figure 6 is a perspective view of an alternative embodiment of an
actuator system of the present invention.
6
CA 02340119 2001-02-19
WO 00/10889 PCT/US99/16948
Figure 7 is a perspective view of another alternative embodiment of an
actuator system of the present invention.
DETAILED DESCRIPTION OF THE PRESENTLY PREFERRED
EMBODIMENTS
The embodiments of the present invention described below are not intended
to be exhaustive or to limit the invention to the precise forms disclosed in
the following
detailed description. Rather the embodiments are chosen and described so that
others
skilled in the art may appreciate and understand the principles and practices
of the present
invention.
FIGS. 1 through 4a show a preferred embodiment of an actuator system 10
of the present invention that may be used to spray precise amounts of a
sprayable
formulation, such as a transdermal drug delivery formulation, over a precise
surface area
of a host animal 11, preferably a mammal, more preferably a human. Actuator
system 10
is particularly suitable for dispensing the "patch in a bottle" compositions
of Assignee's
co-pending U.S. patent application titled SPRAY ON BANDAGE AND DRUG
DELIVERY SYSTEM having Docket No. 53867USASA and filed August 20, 1998, the
entirety of which is incorporated herein by reference.
Actuator system houses vial 12 and is used to dispense a precise amount of
supply 18 onto host 11. Vial 12 includes canister body 14 sealed at one end by
a cover in
the form of valued dispensing element 16. Supply 18 of the formulation to be
sprayed is
stored inside canister body 14. Canister body 14 can be formed from a wide
variety of
materials, but desirably is formed from one or more materials that are
chemically inert
with respect to supply 18 and are suitable for use in connection with
medically active
compositions. Representative examples of suitable materials include a polymer
such as
polyester, polycarbonate, acrylic polymer, polyolefin, polyurethane, silicone,
silicone-
polyurea, silicon polyurethane, fluoropolymer, epoxy, combinations of these or
the like;
glass; glass coated with on or more polymers listed above; stainless steel;
aluminum;
polymer coated (e.g., an epoxy coating) aluminum; combinations of these and
the like.
Vials made from transparent or translucent materials, such as glass, are
preferred, because
7
CA 02340119 2001-02-19
WO 00/10889 PCT/US99/16948
such materials allow the amount and integrity of supply 18 stored in canister
body 14 to be
visually inspected. Particularly preferred aluminum vials are commercially
available from
Minnesota Mining and Manufacturing Company (3M), St. Paul, Minnesota, and come
in a
variety of sizes ranging from 5 cm3 to 22.5 cm3. Particularly preferred
polymer coated
glass vials are commercially available from Wheaton Science Products, a
division of
Lawson Mardon Wheaton, member of the Alusuisse-Lonza Group and come in a
variety of
sizes ranging from 10 ml to about 120 ml.
Valued dispensing element 16 may be of any structure that allows an
amount of supply 18 to be dispensed on demand onto host 11. For example,
valued
dispensing element 16 may be in the form of an element that is biased towards
a closed
position in the absence of an actuating force acting against at least a
portion of element 16,
but is opened to dispense an amount of the formulation in the presence of such
an
actuating force. In such a form, valued dispensing element 16 may be of the
continuous
type through which the formulation is continuously sprayed when valued
dispensing
element 16 is opened. As another option, and more preferably, valued
dispensing element
16 may be of the metered dose type which dispenses a precise amount of the
formulation
each time that the valve is actuated. The metered dose type of valve is
particularly
beneficial in applications in which an accurate dose of a pharmacologically
active agent is
to be delivered to host 11.
Continuous and metered dose valve elements are well known in the art and
have been described in U.S. Pat. Nos. 5,290,539 (Marecki); 4,819,834 (Thief);
4,407,481
(Bolton); 3,052,382 (Gawthrop); 3,049,269 (Gawthrop); 2,980,301 (DeGorter);
2,968,427
(Meshberg); 2,892,576 (Ward); 2,721,010 (Meshberg), all of which are
incorporated
herein by reference in their respective entireties. Continuous and metered
dose valve
elements are also commercially available from 3M. Metered dose valve elements
are
available from 3M that dispense precise amounts of formulation with each
actuation in
discrete volumes in the range from 25 microliters to 100 microliters.
A cross-section of a representative valued dispensing element 16
configured for metered dose delivery of supply 18 is shown in Figs. Sa and Sb.
Element
16 includes mounting cup 22 that sealingly fits in a conventional fashion over
the open end
of canister body 14 (not shown in Figs. Sa and Sb). Metering tank 24 defines
metering
8
CA 02340119 2001-02-19
WO 00/10889 PCT/US99/16948
chamber 26 and is secured inside mounting cup 22 by lip 25 that engages rim
29. Bottom
28 of metering tank 24 fits inside optional retaining cup 23. Retaining cup 23
is in open
communication with the inside of canister body 14 so that retaining cup 23 is
easily filled
with aliquots of supply 18.
Stem 32 extends through and beyond both ends of metering tank 24. One
end 34 of stem 32 extends though orifice 30 of tank bottom 28 and into the
interior of
retaining cup 23. The other end 36 of stem 32 passes out of metering tank 24
and through
orifice 37 of mounting cup in order to extend above element 16. Proximal to
stem end 34,
stem 32 includes inlet channel 35 that allows formulation inside retaining cup
23 to enter
metering chamber 26 when stem 32 is in the closed, extended position of Fig.
Sa. Access
through inlet channel 35 is blocked as stem 32 is depressed from the closed
position of
Fig. Sa to the open position of Fig. Sb. Proximal to stem end 36, outlet
channel 39 allows
formulation inside metering chamber 26 to escape (i.e., be dispensed) into the
ambient.
Access from metering chamber 26 to outlet channel 39 occurs through orifice 38
when
stem 32 is in the open, depressed position of Fig. Sb. Access through orifice
38 is blocked,
and hence no formulation in metering chamber 26 can be dispensed, when stem 32
is in
the extended, closed position of Fig. Sa. Spring 40 biases stem 32 toward the
extended,
closed position of Fig. Sa.
Ferrule gasket 42 helps to establish a liquid tight seal between mounting
cup 22 and canister body 14. Tank seal gasket 44 helps to establish a liquid
tight seal
between stem 32 and metering tank 24 as stem 32 passes through orifice 30 into
retaining
cup 23. Diaphragm 46 helps to establish a liquid tight seal at the open end 47
of metering
tank 24 and around end 36 of stem 32. Shoulder 48 of stem 32 bears against
diaphragm 46
as nan ow neck portion 50 of stem 32 passes through diaphragm orifice 52.
Valved dispensing element 16 is biased to the closed position of Fig. Sa in
which stem 32 is fully extended with shoulder 48 seated against diaphragm 46.
In this
position, inlet channel 35 fluidly connects the inside of retaining cup 23
with metering
chamber 26. This allows a metered amount of formulation to enter metering
chamber 26
from retaining cup 23. Tn the meantime, access into outlet channel 39 via
orifice 38 is
blocked, so that the metered amount of formulation cannot escape from metering
chamber
26.
9
CA 02340119 2001-02-19
WO 00/10889 PCT/US99/16948
To dispense the metered amount of formulation from metering chamber 26,
valve stem 32 is depressed to the position of Fig. Sb. As valve stem 32 is
moved to this
position, access to inlet channel 35 becomes blocked, thus isolating the
metered amount of
formulation inside of metering chamber 26. Further depression of valve 32
causes orifice
38 to move into metering chamber 26, opening access to outlet channel 39. As a
consequence, the metered amount of formulation inside metering chamber 26
becomes
exposed to the ambient. Rapid volatilization of the propellant included in the
formulation
occurs and causes the metered dose to be dispensed from valve stem 32. When
the force
acting to depress valve stem 32 is released, spring 40 biases stem 32 back to
the position
of Fig. Sa, where metering tank 24 is filled with a metered amount of
formulation that is
ready to be dispensed again, on command, so long as enough supply 18 remains
inside
canister body 14.
One important consideration when using a metered dose valve such as
element 16 shown in Figs. Sa and Sb concerns the material that is used to form
gaskets 42,
44, and/or 46. The material of each gasket is preferably an elastomer that
undergoes very
little if any weight loss (due to extraction into the particular formulation
constituting
supply 18), swelling, or leaking when exposed to supply 18 for extended
periods of time.
The elastomer should also be inert with respect to the formulation so that the
properties of
supply 18 and/or the material do not undergo chemical or physical changes that
might
affect the desired kind and degree of performance of actuator system 10 or
supply 18.
In choosing a suitable elastomer, or elastomers, preferred elastomers show
less than 3% weight loss, preferably less than 1% weight loss, when exposed to
a sample
of the formulation to be stored in canister body 14 as supply 18. To test a
gasket for
weight loss, the gasket is initially weighed and then placed into the sample
for 96 hours at
25°C. After such extraction period is carried out, the gasket is dried
and weighed again.
The percent weight loss can then be easily calculated as (1-r) x 100%, where r
is the ratio
of the after-extraction weight to the before-extraction weight.
Desirable elastomers provide gaskets having inner and outer diameters that
each independently show less than about 5%, preferably less than about 2%,
swelling or
shrinkage (as the case may be) when exposed to any component, or combination
of
components to be incorporated into the formulation to be stored in canister
body 14 as
CA 02340119 2001-02-19
WO 00/10889 PCT/US99/16948
supply 18. To test for dimensional changes resulting from exposure to a
particular
chemical (e.g., a solvent, propellant, penetration enhancer, or combinations
thereof), a
minimum of four samples of the gasket material to be tested are placed inside
a swelling
cell that may be sealed from the ambient. This is particularly important when
the chemical
to be tested is a volatile component such as a propellant. The materials
should be secured
to prevent movement around the cell. Stapling the samples to polyethylene is
suitable for
this. Each sample may be assigned a number or the like for easy
identification. The inner
and outer diameters of each sample are measured to within 0.0005 inches
(0.0013 cm).
The measurements are recorded. Theri, the chemical at issue is transferred
into the
swelling cell. Propellants, or other volatile components can be transferred
into the cell via
suitable valuing. Teflon tape may be used as necessary to ensure adequate
seals. The
quality of the seal should be confirmed by immersing the closed cell in a room
temperature waterbath to look for gas bubbles or other indicia of a leak. In
addition to
looking for visually observable phenomena, measurements, e.g., pH,
conductivity, or the
like, can be made of the bath water in order to confirm the integrity of the
seals. The inner
and outer diameters are again measured after 1 day, 3 days, 7 days, 14 days,
and 21 days to
within 0.0005 inches (0.0013 cm). The percentage change in the inner and outer
diameters
is easily calculated according to the expression
% Swelling = (Final diameter - Initial Diameter) x 100
Initial Diameter
Desirable elastomers also provide gaskets that have a percentage weight
loss of less than 3%, preferably less than 1 % when stored at 25°C and
65% relative
humidity for at least 7 days, preferably 14 days, more preferably 28 days. To
test for
leakage, the formulation at issue is placed into a specified number of vials,
typically 2 to
20, each vial being fitted with one or more gaskets formed from the candidate
gasket
material(s). The initial weight of each vial is carefully recorded to the
nearest 0.1 mg. The
vials are then stored under the designated storage conditions. After the
appropriate
interval, e.g., seven days, fourteen days, and 28 days, the vials are weighed
again. The
11
CA 02340119 2001-02-19
WO 00/10889 PCTNS99/16948
vials may be returned to storage for one or more additional testing intervals.
The
percentage weight loss is given by the expression
% weight loss - (Wi - Wn) x 100%
Wi
wherein Wi is the initial weight, in grams; and Wn is the weight as measured
at the end of
the designated interval, in grams.
With these criteria in mind, selecting a suitable elastomer or combination of
elastomers that could be used in one or more of gaskets 42, 44, and 46 will
depend to a
large extent upon the type of ingredients incorporated into supply 18. One of
ordinary skill
in the art, with due consideration to these criteria, will be able to screen a
number of
elastomer samples in order to choose the most suitable elastomer material(s).
Representative examples of elastomers that could be screened for incorporation
into the
gaskets 42, 44, and 46 include butyl rubber, ethylene-propylene-dime rubber
(EPDM,
commercially available under the trade designation KL70L038 from Kirkhill
Rubber Co.,
Brea, CA), neoprene, butadiene-acrylonitrile copolymers ("buna"), copolymers
of 80 to 95
weight percent of ethylene and 5 to 20 weight percent of an alkene (e.g., 1-
butene, I-
hexene, 1-octene, or the like) such as the FLEXOMER DFDA 1085 andlor FLEXOMER
DFDB 1085 copolymers available from Union Carbide, fluoropolymer rubber,
polyurethane, polyamide (e.g., a nylon), rayon, polyolefin, combinations of
these, and the
like. Most preferably, ferrule gasket 42 comprises the DFDA 1085 and/or DFDB
1085
elastomers, and tank seal gasket 44 and diaphragm 46 each comprise the EPDM
rubber.
Referring again to Figs. 1 to 4a, actuator system 10 includes base section 54
having receptacle 56, as one main element, and a dispensing section 70,
preferably in the
form of a vented, funnel-shaped shroud, as another main element. Receptacle 56
is formed
from sidewall 58 coupled to stem receiving section 59. These components define
chamber
60 having bottom wall 62. A longitudinal axis of receptacle 56 extends from
top end 64 to
bottom wall 62. Receptacle 56 thus is open at its top end 64. This allows vial
14 to be
inserted into receptacle 56 in order to carry out acutator operations.
Receptacle 56 is
adapted to receive vial 14 in a manner such that valued dispensing element 16
faces
12
CA 02340119 2006-06-21
downward and is proximal to bottom wall 62. In the preferred embodiment shown,
sidewall 58 is cylindrical to correspond to the shape of vial 14. Of course,
sidewall 58
may have any convenient geometry so long as vial 14 can be positioned and
supported in
receptacle 56 during actuator operation. For example, if vial 14 were to have
a rectilinear
cross-section instead of a cylindrical cross-section, sidewall 58 preferably
would have a
corresponding rectilinear shape as well.
Stem receiving section 59 includes centrally located orifice 66. Orifice 66
provides a passage through which a portion of supply 18 can be sprayed from
vial 14 into
interior 71 of dispensing section 70. Referring to Figs. 1 to 4b, orifice 66
is generally
configured such that stem 32 of valued dispensing element 16 is positioned
within orifice
66 against orifice shoulder 67. Shoulder 67 and stem 32 cooperate to face 27
of element
16 far enough above bottom wall 62 so that stem 32 can be operationally
depressed to
open and close element 16 for dispensing the metered dose of formulation from
metering
chamber 26.
Still refernng primarily to Figs. 1 to 4a, receptacle 56 also preferably
includes at least one vent to allow pressure in receptacle to be equalized
with ambient
pressure during actuator operation as will be described in more detail below.
In the
preferred embodiment shown, such venting is provided by a plurality of vents
68
positioned circumferentially around orifice 66, although one or more vents
(not shown)
optionally could have been provided in sidewall 58 instead of or in addition
to those
provided in stem receiving section 59.
Base section 54 also includes dispensing section 70 extending from the
bottom end of receptacle 56. The dispensing section 70 includes an interior 71
having
throat 74 at top end 72 and mouth 78 at bottom end 76. Throat 74 is in open
communication with orifice 66 allowing an amount of supply 18 to be sprayed on
demand
from vial 14 into interior 71 of dispensing section 70. The sprayed material
leaves the
dispensing section 70 through mouth 78 to be deposited onto host 11.
Dispensing section
70 has a longitudinal axis extending from throat 74 to mouth 78. This
longitudinal axis is
substantially aligned with the longitudinal axis of receptacle 56 so that the
sprayed
formulation travels from vial 14 to the host 11 along a substantially linear
path at least
through dispensing section 70.
13
CA 02340119 2001-02-19
WO 00/10889 PCTNS99/16948
As shown, dispensing section 70 has a preferred funnel shape with a
relatively narrow end corresponding to throat 74 and a relatively wide end
corresponding
to mouth 78. The funnel-shape of dispensing section 70, in combination with
the linear
path of material being sprayed through dispensing section 70, helps to promote
uniform
spray application each time the actuator is used. For example, actuator system
10 of the
present invention can spray a consistent amount of material from a uniform
height over a
uniform area of host 11 to ensure consistent application onto host 11 time
after time. This
is particularly important for applications in which the "patch in a bottle"
technology
(identified above) is used to apply transdermal (or other transtissue),
pharmacologically
active patches onto host 11 for therapeutic treatment.
Preferably, dispensing section 70 also includes one or more vents 80 that
help to dissipate propellant from interior 71 to the ambient in those
embodiments in which
supply 18 includes a propellant. Vents) 80 also help equalize pressure between
dispensing section 70 and the ambient during actuator operations. Vents 68
advantageously allow volatile components of an aerosol spray to be vented to
the ambient
so that pressure build up inside of dispensing section 70 can be released
without
dislodging base section 54 from host 11 during actuation.
Base section 54 preferably further includes a plurality of longitudinal ribs
82 extending along the length of base section 54. Ribs 82 help to strengthen
and provide
structural support for receptacle 56 and dispensing section 70 so that base
section 54
resists twisting or bending during actuator operations. Ribs 82 also provide
guiding
surfaces that slidably engage and support sleeve 88 (described further below)
during
actuator operation. As another preferred feature of base section 54, flange 86
extends
radially outward from bottom end 76. Flange 86 provides a supporting surface
that helps
to stabilize actuator system 10 when placed onto host 11. Flange 86 also
provides a means
for attaching cover 100 (described further below) to dispensing section 70
over mouth 78
when actuator system 10 is not being used.
Sleeve 88 is in the form of a hollow cylinder formed from cylindrical
sidewall 90 and top panel 92. The bottom end 94 of sleeve 88 is open, allowing
sleeve 88
to fit over vial 14 and base section 54 as shown in Fig. 2. The user of
actuator system 10,
who might be host 11 or perhaps a medical professional assisting host 11, can
move sleeve
14
CA 02340119 2001-02-19
WO 00/10889 PCT/US99/16948
88 up and down over base section 54 through a range of motion including a
first, top
position and a second, bottom position. In the first, top position, sleeve 88
is raised up far
enough so that a sufficiently low, or substantially no actuating force acts
against valued
dispensing element 16. Valued dispensing element is thus closed. When moved
downward to a bottom, second position, an actuating force is caused to act
against valued
dispensing element 16 so that element 16 is opened. An amount of supply 18 is
sprayed
from vial I4 as a result.
Such an actuating force may be established using any convenient
mechanism that causes valued dispensing element 16 to open in the desired
manner. In a
preferred embodiment as shown in which valued dispensing element 16 is a
spring
actuated mechanism that opens when an actuating force acts against stem 32,
the actuating
force results when top panel 92 of sleeve 88 pushes stem 32 downward against
shoulder
67. The resultant force causes valued dispensing element 16 to open and
thereby allow an
amount of supply 18 to be sprayed onto host 11. As another advantage, the
valued
dispensing element 16, which includes spring 40, tends to push sleeve 88
upward, biasing
sleeve 88 toward the first position. Of course, if valued dispensing element
16 did not
have this biasing feature, sleeve 88 could be biased upward using any other
conventional
biasing means.
It is desirable to limit the range of motion of sleeve 88 to facilitate ease
of
operation and to avoid damaging vial 14. For example, if the user were able to
push sleeve
88 too far downward in an effort to spray material onto host 11, valued
dispensing element
16 could be crushed or otherwise rendered nonfunctional. As another
possibility, canister
body 14 could break, especially when canister body 14 is made from glass.
Additionally,
the user could force stem 32 too far down into orifice 66 in bottom 62 of
receptacle 56.
On the other hand, if movement of sleeve 88 upward were not limited, the user
could
inadvertently drop vial 14 and base section 54 by grabbing only sleeve 88 when
attempting
to carry actuator system 10. Accordingly, it is desirable to provide actuator
system 10 with
features to limit the range of motion of sleeve 88 between a desired highest
position
beyond which sleeve 88 cannot be raised and a desired lowest position below
which sleeve
88 cannot be pushed. However, the mechanism preferably should still allow
sleeve 88 to
be completely removed when desired so that vial 14 can be placed into and
removed from
CA 02340119 2006-06-21
receptacle 56 as desired. Preferably, these range limiting features comprise
cooperating
means positioned on base section 54 and sleeve 88, respectively.
A preferred structure for limiting the range of motion of sleeve 88 between
desired maximum first and second positions includes one or more finger-like
projections
extending from one of base section 54 and sleeve 88 and a cooperating slot on
the other.
For example, as shown best in Figs. 1 and 4a, sleeve 88 includes one or more,
preferably 2
to 4, slots 96 that receive cooperating fingers 84 extending from ribs 82 of
receptacle 56.
When sleeve 88 is fitted over vial 14 and base section 54, fingers 84 fit into
slots 96. Each
finger 84 is smaller in the longitudinal axial dimension than its slot 96.
This allows sleeve
88 to be raised until fingers 84 reach the bottom of the slots 96. The range
of motion of
sleeve 88 on the downward direction is limited by the amount by which vial 12
can be
pushed downward when stem 32 is depressed. In order to provide a larger
surface area for
fingers 84 to bear against at the top and bottom of slots 96, slots 96
preferably are
positioned in longitudinal ribs 98 positioned along at least a portion of the
length of sleeve
88. Ribs 98 also help to reinforce sleeve 88 so that sleeve 88 has less of a
tendency to be
compressed, twisted, or otherwise distorted when pushed downward to actuate
valued
dispensing element 16. Ribs 98 also provide a convenient means for gripping
sleeve 88.
From the inside of sleeve 88, the ribs 98 provide grooves 97 to slideably
receive ribs 82 of
base section 54 to help guide a sleeve 88 in its vertical travel. As seen but
in Fig. 3b, the
inside of sleeve 88 also may include additional ribs 95 to help maintain axial
alignment of
vial 12 relative to base section 84.
To make it easy to remove sleeve 88 from base section a4 when desired,
sleeve 88 and/or base section 54 desirably include features allowing fingers
84 to be
moved out of slots 96. This can be accomplished if fingers 84 are depressable
or
otherwise movable away from slots 96 in some fashion relative to sleeve 88.
One skilled
in the art could use any convenient approach to accomplish this. However, it
is preferred
that at least one of dispensing section 70 and/or sleeve 88 is resiliently
deformable so that
sleeve 88 can be removed from base section 54 merely by squeezing base section
54 to
cause fingers 84 to deflect inward away from slots 96. Fig. 4b shows an
alternative
embodiment of a base section 54 identical to base section 54 of Fig. 4a except
that ribs 82
of Fig. 4b include cutouts 85 proximal to each finger 84. Cutouts 85 allow
fingers 84 to be
16
CA 02340119 2001-02-19
WO 00/10889 PCT/US99/16948
resiliently depressed by a user to make it easier to place and remove sleeve
88 from base
section 54. Sleeve 88 may also include optimal viewing slot 95 so that the
contents of vial
12 can be visually observed, if desired.
When actuator system 10 is not being used to spray a desired material onto
host 11, it is desirable to cover mouth 78 of dispensing section 70 to help
maintain the
cleanliness of interior 71 between actuator uses. It is also desirable to
secure sleeve 88 in
some fashion that prevents accidental spraying of supply 18. Cover 100 meets
both of
these objectives. Cover 100 includes bottom panel 102 that fits over mouth 78
of
dispensing section 70 to keep dust, dirt, and other debris from collecting
inside dispensing
section 70 when actuator system 10 is not in use. Cover 100 includes arcuate
sleeve 104
formed from sidewall 106 and arcuate top piece 108 that together define hollow
110.
Arcuate sleeve 104 fits over flange 86 to help hold cover 100 in place over
mouth 78.
Preferably, the tolerances between arcuate sleeve 104 and flange 86 provide a
friction fit,
snap fit engagement, or the like, to help hold cover 100 in place. Tab 112
provides a
convenient surface for gripping cover 100 when placing cover 100 over, or
removing cover
100 from, base section 54. Cover 100 also includes an upward extending element
in the
form of ridge 114 that supports and helps hold sleeve 88 in the first position
to physically
prevent sleeve 88 from being accidentally depressed by the user.
Actuator system 10 is extremely easy to use for spraying medical
formulations onto host 11. At the outset, sleeve 88 is removed from base
section 54
allowing vial 14 to be placed into receptacle 56 with valued dispensing
element facing
downward toward bottom 62. Preferably, cover 100 is in place over mouth 78
during this
phase of operations. Once vial 14 is in place, sleeve 88 can be fitted over
vial 14 and base
section 54, making sure that fingers 84 are properly seated in slots 96. With
ridge 114
supporting sleeve 88 in the first position, fingers 84 are located proximal to
the bottoms of
slots 96. Actuator system 10 is now ready to be used. Cover 100 is removed,
preferably
just prior to spraying, and actuator system 10 is then placed over the desired
surface of
host 11 with flange 86 seated against that surface. Now, the user can pull or
push, as the
case may be, sleeve 88 downward. This actuates valued dispensing element 16,
causing an
amount of supply 18 to be sprayed through interior 71 onto host 11. After
spraying,
17
CA 02340119 2001-02-19
WO 00/10889 PCT/US99/16948
actuator system 10 can be lifted off of host 11. Cover 100 may then be
replaced over
mouth 78, and actuator system 10 is ready to be stored until the next desired
use.
An alternative embodiment of the present invention in the form of actuator
system 200 is shown in Fig. 6. There, actuator system includes sleeve 202 and
base
section 204. Vial 206 fits inside chamber 208 of sleeve 202. Sidewall 210 of
sleeve 202
has slot 212 to allow the contents of vial 206 to be visually monitored. Vents
214 are also
provided to avoid pressure build up inside chamber 208 during use. Finger
grips 216
provide a convenient comfortable means for holding sleeve 202 .
Base section 204 includes receptacle 218 and funnel-shaped dispensing
section 220. Receptacle 218 comprises stem receiving section 221 having
orifice 219
configured to receive valve stem 207 of vial 206. Dispensing section 220 is
coupled to the
bottom of receptacle 218 and provides constraining boundaries so that the
sprayed
formulation is dispensed onto a precisely defined area of the host from a
precise height
above the host. Dispensing section 220 includes vents 223 to permit gaseous
components
of the sprayed formulation, e.g., a propellant, solvent, or the like, to
escape to the ambient.
Rubber gasket 222 engages the bottom end of funnel section 220 and helps to
form an
effective seal between funnel section 220 and the surface onto which
formulation is being
sprayed.
Sleeve 202 in this embodiment is open at both the top and bottom ends.
Thus, to help support vial 206 during use, ribs 224 extended outward from
dispensing
section 204 and provide a plurality of planar support surfaces 226 upon which
vial 206 can
be supported when valve stem 207 is depressed. In the sense that a purpose of
receptacle
218 is to support and couple vial 206 to base section 204, planar support
surfaces 226 can
be considered to be part of receptacle 218. Ribs 224 also help to strengthen
dispensing
section 204 as well.
In use, stem 207 is fitted into orifice 219 while sleeve 202 is fitted around
vial 206. The user places gasket 222 firmly against the desired substrate
surface, holding
system 200 in place with one hand. The palm or thumb of the other hand is
placed over
the bottom of vial 206, with the fingers engaging the flared portion of sleeve
202 at finger
grips 216. The user gently pushes downward on vial 206 and sleeve 202 in order
to
18
CA 02340119 2001-02-19
WO 00/10889 PCT/US99/16948
depress valve and dispense a metered amount of formulation from a precise
height onto a
precise area of the substrate.
An alternative embodiment of the present invention in the form of actuator
system 300 is shown in Fig. 7. System 300 includes base section 302 including
receptacle
304 and funnel-shaped dispensing section 306. Receptacle 304 includes stem
receiving
section 308 including an orifice (not shown) to receive stem 310 of vial 312.
Cylindrical
section 314 of receptacle 304 defines pocket 316 in order to help support vial
312. Cover
318 fits over funnel-shaped dispensing section 306 when system 300 is not
being used to
dispense a formulation onto a host. Cover 318 includes tab 320 that engages
rim of
cylindrical section 314 to make is easier to remove or replace cover 318.
Other embodiments of this invention will be apparent to those skilled in
the art upon consideration of this specification or from practice of the
invention
disclosed herein. Various omissions, modifications, and changes to the
principles and
embodiments described herein may be made by one skilled in the art without
departing
from the true scope and spirit of the invention which is indicated by the
following
claims.
19
